Zdrowie i gospodarka · 07/04/2022

FDA Announces Final Guidance for Developing Drugs to Treat Chronic Hepatitis B Virus Infection

The FDA has released a final guidance to help pharmaceutical companies develop effective treatments for chronic hepatitis B virus infection, covering the entire drug development process from initial testing to post-marketing phases.